AMENDMENT #1 TO THE PLASMA SUPPLY AGREEMENT (HEPATITIS B PLASMA – BPC TO ADMA)Plasma Supply Agreement • August 10th, 2018 • Adma Biologics, Inc. • Biological products, (no disgnostic substances)
This Amendment #1 to the Plasma Supply Agreement (this “Amendment #1”), effective as of July 19, 2018 (“Effective Date”), is by and between Biotest Pharmaceuticals Corporation, a Delaware corporation, having a place of business at 901 Yamato Road, Suite 101, Boca Raton, Florida 33431 (“BPC”) and ADMA BioManufacturing, LLC, a Delaware limited liability company, having a place of business at 5800 Park of Commerce Boulevard NW, Boca Raton, Florida 33487 (“ADMA”).
SHARE TRANSFER, AMENDMENT AND RELEASE AGREEMENTShare Transfer Agreement • August 10th, 2018 • Adma Biologics, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS SHARE TRANSFER, AMENDMENT AND RELEASE AGREEMENT (this “Agreement”), dated as of May 14, 2018 (the “Execution Date”), is entered into by and among BIOTEST PHARMACEUTICALS CORPORATION, a Delaware corporation (“BPC”), ADMA BIOMANUFACTURING, LLC, a Delaware limited liability company (“ADMA BioManufacturing”), ADMA BIOLOGICS, INC., a Delaware corporation (“ADMA Biologics” and, together with ADMA BioManufacturing, “ADMA”)), ADMA BIO CENTERS GEORGIA INC., a Delaware corporation (“ADMA BioCenters”), BIOTEST AG, a company organized under the laws of Germany (“Biotest”), THE BIOTEST DIVESTITURE TRUST, a Maryland trust (the “Trust”) and BIOTEST US CORPORATION, a Delaware corporation (“Biotest US”). Each of BPC, ADMA, ADMA BioCenters, Biotest, the Trust and Biotest US are sometimes referred to herein, individually, as a “Party” and, collectively, as the “Parties.”
